Abemaciclib combined with endocrine therapy for the adjuvant treatment of HR1, HER22, node-positive, high-risk, early breast cancer (monarchE)

  1. Johnston, S.R.D.
  2. Harbeck, N.
  3. Hegg, R.
  4. Toi, M.
  5. Martin, M.
  6. Shao, Z.M.
  7. Zhang, Q.Y.
  8. Rodriguez, J.L.M.
  9. Campone, M.
  10. Hamilton, E.
  11. Sohn, J.
  12. Guarneri, V.
  13. Okada, M.
  14. Boyle, F.
  15. Neven, P.
  16. Cortés, J.
  17. Huober, J.
  18. Wardley, A.
  19. Tolaney, S.M.
  20. Cicin, I.
  21. Smith, I.C.
  22. Frenzel, M.
  23. Headley, D.
  24. Wei, R.
  25. Antonio, B.S.
  26. Hulstijn, M.
  27. Cox, J.
  28. O'Shaughnessy, J.
  29. Rastogi, P.
  30. Erakutsi egile guztiak +
Aldizkaria:
Journal of Clinical Oncology

ISSN: 1527-7755,  0732-183X

Argitalpen urtea: 2020

Alea: 38

Zenbakia: 34

Orrialdeak: 3987-3998

Mota: Artikulua

DOI: 10.1200/JCO.20.02514 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus